Skip to content
Micromedic Technologies Ltd. logo — Micromedic Technologies specializes in the development and c...

Micromedic Technologies Ltd.

Micromedic Technologies specializes in the development and commercialization of innovative in vitro cancer diagnostics

Founded 1982 Israel Israel 1 employees Post-IPO Equity Total: $21.00M Health Care

General Information

Company Name Micromedic Technologies Ltd.
Founded Year 1982
Location Israel Israel
Founders / Decision Makers
Team member
Employees 1
Industries Health Care
Funding Stage Post-IPO Equity
Social

BounceWatch is an independent company data service, not affiliated with Micromedic Technologies Ltd.. To contact Micromedic Technologies Ltd., visit m-medic.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Micromedic Technologies Ltd. compare?

A PDF of Micromedic Technologies Ltd. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Micromedic Technologies Ltd. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Micromedic Technologies Ltd.

Micromedic Technologies is a pioneering company in the field of in vitro cancer diagnostics. Founded in 1982 and headquartered in Israel, the company focuses on developing and commercializing cutting-edge diagnostic products and solutions for early cancer detection and personalized medicine. Their flagship product, CellDetect®, is a groundbreaking diagnostic platform with applications across multiple cancer types. It leverages a unique histochemical stain that allows color discrimination alongside morphological examination, enabling differentiation between normal and cancer cells in various sample types including biopsy, urine, smear, and blood. Micromedic's CellDetect® Bladder cancer test is a game-changer in the industry, offering high performance, cost-effectiveness, and a familiar workflow, unavailable in other bladder cancer tests. Clinical studies have demonstrated its high sensitivity for early-stage tumors, enhancing the prospect of early detection and prognosis improvement. The company received a ILS3.40M post-IPO equity investment on 01 January 2019 from Cybele Holdings. Micromedic's innovative technologies have the potential to revolutionize cancer diagnostics, facilitating pathologists' examination, reducing the need for expert analysis, and cutting lab costs. Their emphasis on early cancer detection and personalized medicine aligns with the increasing demand for advanced diagnostic solutions in the Health Care industry. With strong financial backing and a game-changing product portfolio, Micromedic is poised to make significant contributions to the future of cancer diagnostics and treatment.

Business keywords: Cancer diagnostics, In vitro diagnostics, CellDetect technology, Bladder cancer test, Personalized medicine, Early cancer detection, Pathology, Clinical studies, Digital pathology, Tumor detection, Biopsy, Liquid-based cytology, Morphological examination, Color discrimination, Innovation

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Equity ILS3.40M 1
Cybele Holdings
01 Jan 2019
Post IPO Equity ILS2.80M 1
Cybele Holdings
01 Jun 2018
Post IPO Equity ILS2.00M 1
Cybele Holdings
01 Dec 2017
Post IPO Equity ILS2.30M -
01 Sep 2017
Post IPO Equity ILS3.80M -
01 Jul 2016
Post IPO Equity ILS6.70M -
01 May 2015

Micromedic Technologies Ltd. Alternatives & Competitors

View All Alternatives
Micromedic Technologies Ltd. vs
VisionGate, Inc.
VisionGate, Inc. United States

Leading the Battle Against Lung Cancer through our Early Detection Technology

Venture round
24 employees
Biotechnology, Health Care
Micromedic Technologies Ltd. vs
CellMax Life
CellMax Life United States

Liquid biopsy company focused on cancer screening with a proprietary platform for detecting precance...

25 employees
Biotechnology, Health Care
Micromedic Technologies Ltd. vs
Amadix
Amadix Spain

Early cancer detection in blood

Grant
43 employees
Biopharma, Biotechnology

FAQ About Micromedic Technologies Ltd.

Micromedic Technologies specializes in the development and commercialization of innovative in vitro cancer diagnostics
Micromedic Technologies Ltd. was founded in 1982.
Micromedic Technologies Ltd. is headquartered in Israel.
Micromedic Technologies Ltd. operates in Health Care. Its work centres on Cancer diagnostics, In vitro diagnostics, CellDetect technology and Bladder cancer test.
Micromedic Technologies Ltd. has approximately 1 employees.
Micromedic Technologies Ltd. has completed 6 funding rounds, raising a total of $21.00M. The latest funding stage is Post-IPO Equity.
Top alternatives and competitors to Micromedic Technologies Ltd. include VisionGate, Inc., CellMax Life, Amadix, JL MediLabs Inc., Exai Bio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Micromedic Technologies Ltd. and VisionGate, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Micromedic Technologies Ltd., https://bouncewatch.com/company/micromedic, updated 24 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout